Table 1 Clinical and biochemical characteristics of the 961 participants
From: Impact of chronic diuretic treatment on glucose homeostasis
|  | Mean ± SD | Median (Q1-Q3) |
|---|---|---|
Age (y) | 49 ± 14 | 50 (38–60) |
Body weight (kg) | 73.6 ± 15.9 | 72.0 (61.6 - 83.5 |
BMI (kg/m2) | 27.9 ± 5.4 | 27.2 (24.1-31.0) |
Circumferences | Â | Â |
   Waist (cm) | 94.3 ± 14.5 | 94.0 (85.0 - 103.0) |
   Hip (cm) | 104.6 ± 12.3 | 104.0 (98.0 - 110.0) |
Systolic BP (mmHg) | 129 ± 16 | 128 (118–139) |
Diastolic BP (mmHg) | 79 ± 10 | 78 (72–85) |
Heart rate (beats/min) | 74 ± 11 | 73 (66–81) |
Random capillary blood glucose (mg/dl) | 91 ± 12 | 90 (82–97) |
Blood concentration of | n = 507 |  |
   glycated hemoglobin% | 5.6 ± 0.4 | 5.5 (5.3 - 5.8) |
mmol/mol | 37.4 ± 4.8 | 36.6 (34.4 - 39.9) |
   glucose (mg/dl) | 88 ± 21 | 85 (75–97) |
   total cholesterol (mg/dl) | 213 ± 39 | 212 (185–240) |
   hdl cholesterol (mg/dl) | 59 ± 15 | 58 (49–67) |
   triglycerides (mg/dl) | 101 ± 49 | 90 (68–121) |
   ldl cholesterol (mg/dl) | 133 ± 36 | 131 (108–161) |
   uric acid (mg/dl) | 5.0 ± 1.4 | 4.7 (3.9 - 5.9) |
   insulin (μu/ml) | 9.6 ± 5.8 | 8.2 (5.6 - 11.8) |
HOMA-IR | 2.2 ± 1.5 | 1.8 (1.2 - 2.7) |
HOMA-β | 141.8 ± 104.5 | 117.9 (80.0 - 171.4) |
   Creatinine (mg/dL) | 0.83 ± 0.21 | 0.79 (0.69 - 0.94) |
   eGFR-MDRD (mL/min/1.73 m2) | 91.8 ± 20.3 | 90.3 (76.5 – 94.4) |